Our mission at Kriya Therapeutics is to expand the reach of gene therapy to address highly prevalent diseases affecting millions of patients.
Location: United States, California, Redwood City
Employees: 51-200
Total raised: $370M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | T1D Fund | t1dfund.or... |
| - | BlueBird V... | bluebirdvc... |
| - | Narya | naryavc.co... |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.05.2022 | Series C | $270M | - |
| 16.07.2021 | Series B | $100M | Foresite C... |
Mentions in press and media 12
| Date | Title | Description |
| 11.09.2025 | Kriya Raises $320M in Series D Financing | Kriya Therapeutics, a Research Triangle Park, NC-based clinical-stage biopharmaceutical company developing gene therapies for chronic diseases of high unmet need, raised $320M in Series D financing. The round was co-led by Patient Square Ca... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital flowing into the industry. While biotech VC investments in 2022 failed to live up to 2021's banner year, the second half still saw a steady st... |
| 18.11.2022 | Kriya Acquires Redpin Therapeutics | Kriya, a Redwood City CA, and Research Triangle Park, NC-based gene therapy company, acquired Redpin Therapeutics, a New York-based biotechnology company. The amount of the deal was not disclosed. The acquisition serves as the foundation fo... |
| 18.05.2022 | What to know about Instacart’s IPO | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Last week was an interesting one for Instacart to start the process of going public. Paid Content... |
| 17.05.2022 | Kriya Therapeutics Raises $270M in Series C Financing | Kriya Therapeutics, Inc., a Redwood City, CA and Research Triangle Park, NC-based fully integrated gene therapy company advancing novel technologies and therapeutics, raised $270m in Series C financing. The round was led by Patient Square C... |
| 16.05.2022 | Kriya cashes in $270M series C to further finance all-in-one gene therapy biz | Kriya Therapeutics has reeled in a whopping $270 million from its series C round, surpassing the $180 million raised in total over the last two years and solidifying ample financing to build out its all-in-one gene therapy business. Led by ... |
| 20.07.2021 | Digital health news, funding roundup in the prior week; July 18 | With $150B already invested, VC is set to have another recording breaking year With $150B already invested, VC is set to have another recording breaking year. There was $75 billion invested across an estimated 4,302 deals in the second quar... |
| 15.07.2021 | Kriya Therapeutics lands $100M | Gene therapy startup Kriya Therapeutics has closed a $100 million Series B led by Patient Square Capital, with participation from new and existing investors including Woodline Partners, Alumni Ventures, Narya Capital, Foresite Capital and J... |
| 14.07.2021 | Kriya Therapeutics Completes $100 Million Series B Financing to Advance Its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies | Financing led by Patient Square Capital with participation from leading life sciences investors to support the further development of Kriya’s core technology platforms, advancement of its current programs and continued expansion of its pipe... |
| 12.02.2021 | George Church and an entrepreneurial postdoc join the hunt for AAV 2.0 with a new vector-cloaking technology | In 2018, when Vivek Ramaswamy’s Axovant failed multiple trials on its lead dementia drug and pivoted the entire company toward gene therapy, one employee took a particular liking to the new science: Vivek’s brother, Shankar Ramaswamy. Now S... |
Show more